Jupiter Infomedia Limited (BOM:534623)

Verve Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	96.29	60.63	17.12	4.9	0.68
Short-Term Investments	-	29.48	15.3	8.1	1.74	-
Trading Asset Securities	-	-	9.82	10.26	10.86	2.98
Cash & Short-Term Investments	125.77	125.77	85.74	35.48	17.5	3.66
Cash Growth	65.65%	46.69%	141.63%	102.71%	378.12%	13.70%
Accounts Receivable	-	0.1	0.02	32.64	0.03	0.01
Other Receivables	-	3.22	1.01	1.01	0.57	9.93
Receivables	-	3.32	1.03	33.65	0.6	9.95
Inventory	-	15.95	-	-	0.03	0.03
Other Current Assets	-	24.49	24.3	26.76	27.7	4.97
Total Current Assets	-	169.52	111.07	95.89	45.83	18.61
Property, Plant & Equipment	-	6.11	8.25	6.12	5.97	4.92
Long-Term Investments	-	206.21	194.3	98.1	72.12	0.86
Other Intangible Assets	-	1.38	2.88	4.6	6.54	1.38
Long-Term Deferred Tax Assets	-	-	-	-	4.98	3.88
Other Long-Term Assets	-	12.99	14.03	32.39	37.56	44.7
Total Assets	-	401.21	343.02	249.61	185.51	102.47
Accounts Payable	-	-	-	0.91	0.35	0.04
Accrued Expenses	-	0.71	10.38	10.3	0.03	0.02
Current Portion of Leases	-	0.11	-	-	-	-
Other Current Liabilities	-	-0	0.1	0.09	2.48	0.11
Total Current Liabilities	-	0.81	10.47	11.29	2.85	0.16
Long-Term Leases	-	0.11	7.13	0.46	-	-
Long-Term Deferred Tax Liabilities	-	5.94	-	-	-	-
Other Long-Term Liabilities	-	0	0.22	2.79	-	-
Total Liabilities	-	6.86	17.82	14.54	2.85	0.16
Common Stock	-	100.2	100.2	100.2	100.2	100.2
Additional Paid-In Capital	-	-	3.75	3.75	3.75	3.75
Retained Earnings	-	-	86.76	34.75	0.79	-1.65
Comprehensive Income & Other	-	160.49	38.11	35.53	35.53	0
Total Common Equity	260.69	260.69	228.83	174.24	140.28	102.31
Minority Interest	-	133.66	96.37	60.83	42.38	-
Shareholders' Equity	394.35	394.35	325.2	235.07	182.66	102.31
Total Liabilities & Equity	-	401.21	343.02	249.61	185.51	102.47
Total Debt	0.22	0.22	7.13	0.46	-	-
Net Cash (Debt)	125.55	125.55	78.6	35.03	17.5	3.66
Net Cash Growth	66.05%	59.72%	124.41%	100.10%	378.12%	13.70%
Net Cash Per Share	12.52	12.53	7.84	3.50	1.75	0.37
Filing Date Shares Outstanding	10.04	10.03	10.02	10.02	10.02	10.02
Total Common Shares Outstanding	10.04	10.03	10.02	10.02	10.02	10.02
Working Capital	-	168.71	100.6	84.6	42.98	18.44
Book Value Per Share	25.98	25.98	22.84	17.39	14.00	10.21
Tangible Book Value	259.31	259.31	225.95	169.64	133.74	100.93
Tangible Book Value Per Share	25.84	25.84	22.55	16.93	13.35	10.07
Buildings	-	-	-	-	6.41	6.41
Machinery	-	-	6.92	6.56	6.69	3.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.